Other Species / Isoforms
  NKCC1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S23-p
AGVGETPsAAALAAA
0 2
NKCC1 (human) AGVGETPsAAALAAA S23-p
NKCC1 iso3 (human) AGVGETPSAAALAAA S23
NKCC1 (mouse) gap -
NKCC1 (rat) gap -
T75-p
LGRPLGPtPsQsRFQ
0 2
NKCC1 (human) LGRPLGPtPsQsRFQ T75-p
NKCC1 iso3 (human) LGRPLGPTPSQSRFQ T75
NKCC1 (mouse) LGRPLGPTPsQsRFQ T72
NKCC1 (rat) LGKPLGPTPsQSRFQ T71
S77-p
RPLGPtPsQsRFQVD
Upstream
Downstream
2 22
Effects on Modified Protein
  • activity, inhibited
Kinase, in vitro:
  • AMPKA1 (human)
  • AMPKA1 (rat)
Putative in vivo kinases:
  • AMPKA1 (human)
Treatment
  • A-769662
  • SII_angiotensin_2
NKCC1 (human) RPLGPtPsQsRFQVD S77-p
NKCC1 iso3 (human) RPLGPTPSQSRFQVD S77
NKCC1 (mouse) RPLGPTPsQsRFQVD S74-p
NKCC1 (rat) KPLGPTPsQSRFQVD S73-p
S79-p
LGPtPsQsRFQVDLV
0 8
NKCC1 (human) LGPtPsQsRFQVDLV S79-p
NKCC1 iso3 (human) LGPTPSQSRFQVDLV S79
NKCC1 (mouse) LGPTPsQsRFQVDPV S76-p
NKCC1 (rat) LGPTPsQSRFQVDPV S75
S87-p
RFQVDLVsENAGRAA
0 1
NKCC1 (human) RFQVDLVsENAGRAA S87-p
NKCC1 iso3 (human) RFQVDLVSENAGRAA S87
NKCC1 (mouse) RFQVDPVSENAGRAA S84
NKCC1 (rat) RFQVDPVSENAGRAA S83
K114-ub
AGAGAGAkQTPADGE
0 1
NKCC1 (human) AGAGAGAkQTPADGE K114-ub
NKCC1 iso3 (human) AGAGAGAKQTPADGE K114
NKCC1 (mouse) AAAGAAGKETPAAGK K109
NKCC1 (rat) AAAGAAGKETPAAGK K107
S123-p
TPADGEAsGESEPAk
0 1
NKCC1 (human) TPADGEAsGESEPAk S123-p
NKCC1 iso3 (human) TPADGEASGESEPAK S123
NKCC1 (mouse) TPAAGKAGGESGVAK G118
NKCC1 (rat) TPAAGKAGTESGVAK G116
K130-ub
sGESEPAkGsEEAkG
0 1
NKCC1 (human) sGESEPAkGsEEAkG K130-ub
NKCC1 iso3 (human) SGESEPAKGSEEAKG K130
NKCC1 (mouse) GGESGVAKGSEEAKG K125
NKCC1 (rat) GTESGVAKGSEEAKG K123
S132-p
ESEPAkGsEEAkGRF
0 3
NKCC1 (human) ESEPAkGsEEAkGRF S132-p
NKCC1 iso3 (human) ESEPAKGSEEAKGRF S132
NKCC1 (mouse) ESGVAKGSEEAKGRF S127
NKCC1 (rat) ESGVAKGSEEAKGRF S125
K136-ub
AkGsEEAkGRFRVNF
0 1
NKCC1 (human) AkGsEEAkGRFRVNF K136-ub
NKCC1 iso3 (human) AKGSEEAKGRFRVNF K136
NKCC1 (mouse) AKGSEEAKGRFRVNF K131
NKCC1 (rat) AKGSEEAKGRFRVNF K129
T203-p
HQHYYYDtHTNtyYL
Upstream
Downstream
11 1
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • OSR1 (human)
  • STLK3 (human)
Putative in vivo kinases:
  • OSR1 (human)
Regulatory protein:
  • CAB39 (human)
  • OSR1 (human)
  • WNK1 (human)
  • WNK3 (human)
Treatment
  • A-769662
  • hypotonic_buffer
  • intraventricular hemorrhage
  • low_chloride
  • siRNA
  • sorbitol
  • sucrose
NKCC1 (human) HQHYYYDtHTNtyYL T203-p
NKCC1 iso3 (human) HQHYYYDTHTNTYYL T203
NKCC1 (mouse) HQQYYYDtHTNtYYL T196-p
NKCC1 (rat) HQQYYYDTHTNTYYL T194
T207-p
YYDtHTNtyYLRtFG
Upstream
Downstream
12 1
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • OSR1 (human)
  • STLK3 (human)
Putative in vivo kinases:
  • OSR1 (human)
Regulatory protein:
  • CAB39 (human)
  • OSR1 (human)
  • WNK1 (human)
  • WNK3 (human)
Treatment
  • A-769662
  • hypotonic_buffer
  • intraventricular hemorrhage
  • low_chloride
  • siRNA
  • sorbitol
  • sucrose
NKCC1 (human) YYDtHTNtyYLRtFG T207-p
NKCC1 iso3 (human) YYDTHTNTYYLRTFG T207
NKCC1 (mouse) YYDtHTNtYYLRtFG T200-p
NKCC1 (rat) YYDTHTNTYYLRtFG T198
Y208-p
YDtHTNtyYLRtFGH
0 8
NKCC1 (human) YDtHTNtyYLRtFGH Y208-p
NKCC1 iso3 (human) YDTHTNTYYLRTFGH Y208
NKCC1 (mouse) YDtHTNtYYLRtFGH Y201
NKCC1 (rat) YDTHTNTYYLRtFGH Y199
T212-p
TNtyYLRtFGHNtMD
Upstream
Downstream
20 28
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • OSR1 (human)
  • STLK3 (human)
Putative in vivo kinases:
  • OSR1 (human)
Regulatory protein:
  • CAB39 (human)
  • OSR1 (human)
  • WNK1 (human)
  • WNK3 (human)
Treatment
  • A-769662
  • A79662
  • BI2536
  • calyculin_A
  • colforsin
  • compound_C
  • hypotonic_buffer
  • intraventricular hemorrhage
  • low_chloride
  • osmotic_stress
  • siRNA
  • sorbitol
  • sucrose
NKCC1 (human) TNtyYLRtFGHNtMD T212-p
NKCC1 iso3 (human) TNTYYLRTFGHNTMD T212
NKCC1 (mouse) TNtYYLRtFGHNtMD T205-p
NKCC1 (rat) TNTYYLRtFGHNtMD T203-p
T217-p
LRtFGHNtMDAVPRI
Upstream
Downstream
9 53
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • OSR1 (human)
Treatment
  • A79662
  • BI2536
  • calyculin_A
  • colforsin
  • compound_C
  • EGF
  • hypotonic_buffer
  • osmotic_stress
NKCC1 (human) LRtFGHNtMDAVPRI T217-p
NKCC1 iso3 (human) LRTFGHNTMDAVPRI T217
NKCC1 (mouse) LRtFGHNtMDAVPRI T210-p
NKCC1 (rat) LRtFGHNtMDAVPRI T208-p
Y227-p
AVPRIDHyRHtAAQL
Upstream
0 44
Treatment
  • Su11274
NKCC1 (human) AVPRIDHyRHtAAQL Y227-p
NKCC1 iso3 (human) AVPRIDHYRHTAAQL Y227
NKCC1 (mouse) AVPRIDHYRHtAAQL Y220
NKCC1 (rat) AVPRIDHYRHTAAQL Y218
T230-p
RIDHyRHtAAQLGEk
Upstream
Downstream
3 10
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • OSR1 (human)
Treatment
  • osmotic_stress
NKCC1 (human) RIDHyRHtAAQLGEk T230-p
NKCC1 iso3 (human) RIDHYRHTAAQLGEK T230
NKCC1 (mouse) RIDHYRHtAAQLGEK T223-p
NKCC1 (rat) RIDHYRHTAAQLGEK T221
K237-ub
tAAQLGEkLLRPsLA
0 3
NKCC1 (human) tAAQLGEkLLRPsLA K237-ub
NKCC1 iso3 (human) TAAQLGEKLLRPSLA K237
NKCC1 (mouse) tAAQLGEKLLRPSLA K230
NKCC1 (rat) TAAQLGEKLLRPSLG K228
S242-p
GEkLLRPsLAELHDE
Upstream
1 8
Kinase, in vitro:
  • AMPKA1 (human)
Putative in vivo kinases:
  • AMPKA1 (human)
Treatment
  • A-769662
NKCC1 (human) GEkLLRPsLAELHDE S242-p
NKCC1 iso3 (human) GEKLLRPSLAELHDE S242
NKCC1 (mouse) GEKLLRPSLAELHDE S235
NKCC1 (rat) GEKLLRPSLGEFHDE S233
K252-ub
ELHDELEkEPFEDGF
0 13
NKCC1 (human) ELHDELEkEPFEDGF K252-ub
NKCC1 iso3 (human) ELHDELEKEPFEDGF K252
NKCC1 (mouse) ELHDELEkEPFEDGF K245-ub
NKCC1 (rat) EFHDELEKEPFEDGF K243
S265-p
GFANGEEstPtRDAV
0 9
NKCC1 (human) GFANGEEstPtRDAV S265-p
NKCC1 iso3 (human) GFANGEESTPTRDAV S265
NKCC1 (mouse) GFANGEEstPTRDAV S258-p
NKCC1 (rat) GFANGEEStPTRDAV S256
T266-p
FANGEEstPtRDAVV
0 25
NKCC1 (human) FANGEEstPtRDAVV T266-p
NKCC1 iso3 (human) FANGEESTPTRDAVV T266
NKCC1 (mouse) FANGEEstPTRDAVV T259-p
NKCC1 (rat) FANGEEStPTRDAVV T257-p
T268-p
NGEEstPtRDAVVTy
0 2
NKCC1 (human) NGEEstPtRDAVVTy T268-p
NKCC1 iso3 (human) NGEESTPTRDAVVTY T268
NKCC1 (mouse) NGEEstPTRDAVVAy T261
NKCC1 (rat) NGEEStPTRDAVVTY T259
Y275-p
tRDAVVTytAESkGV
Upstream
0 98
Treatment
  • ephrin_B1
  • gefitinib
  • imatinib
  • Su11274
NKCC1 (human) tRDAVVTytAESkGV Y275-p
NKCC1 iso3 (human) TRDAVVTYTAESKGV Y275
NKCC1 (mouse) TRDAVVAyTAESkGV Y268-p
NKCC1 (rat) TRDAVVTYTAESKGV Y266
T276-p
RDAVVTytAESkGVV
0 11
NKCC1 (human) RDAVVTytAESkGVV T276-p
NKCC1 iso3 (human) RDAVVTYTAESKGVV T276
NKCC1 (mouse) RDAVVAyTAESkGVV T269
NKCC1 (rat) RDAVVTYTAESKGVV T267
K280-ub
VTytAESkGVVKFGW
0 8
NKCC1 (human) VTytAESkGVVKFGW K280-ub
NKCC1 iso3 (human) VTYTAESKGVVKFGW K280
NKCC1 (mouse) VAyTAESkGVVKFGW K273-ub
NKCC1 (rat) VTYTAESKGVVKFGW K271
Y353-p
FVRGGGAyYLISRSL
0 1
NKCC1 (human) FVRGGGAyYLISRSL Y353-p
NKCC1 iso3 (human) FVRGGGAYYLISRSL Y353
NKCC1 (mouse) FVRGGGAYYLISRSL Y346
NKCC1 (rat) FVRGGGAYyLISRSL Y344
Y354
VRGGGAyYLISRSLG
0 2
NKCC1 (human) VRGGGAyYLISRSLG Y354
NKCC1 iso3 (human) VRGGGAYYLISRSLG Y354
NKCC1 (mouse) VRGGGAYYLISRSLG Y347
NKCC1 (rat) VRGGGAYyLISRSLG Y345-p
N553
RDATGNVNDTIVTEL
0 1
NKCC1 (human) RDATGNVNDTIVTEL N553
NKCC1 iso3 (human) RDATGNVNDTIVTEL N553
NKCC1 (mouse) RDATGNVnDTITTEL N546-ng
NKCC1 (rat) RDATGNVNDTITTEL N544
N562
TIVTELTNCTSAACK
0 1
NKCC1 (human) TIVTELTNCTSAACK N562
NKCC1 iso3 (human) TIVTELTNCTSAACK N562
NKCC1 (mouse) TITTELTnCTSAACK N555-ng
NKCC1 (rat) TITTELTNCTSAACK N553
K631
KIFQALCKDNIYPAF
0 1
NKCC1 (human) KIFQALCKDNIYPAF K631
NKCC1 iso3 (human) KIFQALCKDNIYPAF K631
NKCC1 (mouse) KIFQALCkDNIYPAF K624-ub
NKCC1 (rat) KIFQALCKDNIYPAF K622
K833-ub
GPRRQAMkEMsIDQA
0 4
NKCC1 (human) GPRRQAMkEMsIDQA K833-ub
NKCC1 iso3 (human) GPRRQAMKEMSIDQA K833
NKCC1 (mouse) GPRRQAMkEMSIDQA K826-ub
NKCC1 (rat) GPRRQAMKEMSIDQA K824
K833-m1
GPRRQAMkEMsIDQA
0 1
NKCC1 (human) GPRRQAMkEMsIDQA K833-m1
NKCC1 iso3 (human) GPRRQAMKEMSIDQA K833
NKCC1 (mouse) GPRRQAMKEMSIDQA K826
NKCC1 (rat) GPRRQAMKEMSIDQA K824
S836-p
RQAMkEMsIDQAkyQ
0 1
NKCC1 (human) RQAMkEMsIDQAkyQ S836-p
NKCC1 iso3 (human) RQAMKEMSIDQAKYQ S836
NKCC1 (mouse) RQAMkEMSIDQARYQ S829
NKCC1 (rat) RQAMKEMSIDQAkYQ S827
K841
EMsIDQAKyQRWLIK
0 1
NKCC1 (human) EMsIDQAKyQRWLIK K841
NKCC1 iso3 (human) EMSIDQAKYQRWLIK K841
NKCC1 (mouse) EMSIDQARYQRWLIk R834
NKCC1 (rat) EMSIDQAkYQRWLIK K832-ac
K841-ub
EMsIDQAkyQRWLIK
0 2
NKCC1 (human) EMsIDQAkyQRWLIK K841-ub
NKCC1 iso3 (human) EMSIDQAKYQRWLIK K841
NKCC1 (mouse) EMSIDQARYQRWLIk R834
NKCC1 (rat) EMSIDQAKYQRWLIK K832
Y842-p
MsIDQAkyQRWLIKN
0 1
NKCC1 (human) MsIDQAkyQRWLIKN Y842-p
NKCC1 iso3 (human) MSIDQAKYQRWLIKN Y842
NKCC1 (mouse) MSIDQARYQRWLIkN Y835
NKCC1 (rat) MSIDQAkYQRWLIKN Y833
K848
kyQRWLIKNKMKAFy
0 7
NKCC1 (human) kyQRWLIKNKMKAFy K848
NKCC1 iso3 (human) KYQRWLIKNKMKAFY K848
NKCC1 (mouse) RYQRWLIkNKMKAFY K841-ub
NKCC1 (rat) kYQRWLIKNKMKAFY K839
Y855-p
KNKMKAFyAPVHADD
0 1
NKCC1 (human) KNKMKAFyAPVHADD Y855-p
NKCC1 iso3 (human) KNKMKAFYAPVHADD Y855
NKCC1 (mouse) kNKMKAFYAPVHADD Y848
NKCC1 (rat) KNKMKAFYAPVHADD Y846
K923-ub
GVVVIRLkEGLDISH
0 1
NKCC1 (human) GVVVIRLkEGLDISH K923-ub
NKCC1 iso3 (human) GVVVIRLKEGLDISH K923
NKCC1 (mouse) GVVVIRLKEGLDISH K916
NKCC1 (rat) GVVVIRLKEGLDISH K914
S940-p
GQEELLSsQEksPGt
0 8
NKCC1 (human) GQEELLSsQEksPGt S940-p
NKCC1 iso3 (human) GQEELLSSQEKSPGT S940
NKCC1 (mouse) GQEELLSsQEksPGT S933-p
NKCC1 (rat) GQEELLSsQEKSPGT S931-p
K943-ub
ELLSsQEksPGtkDV
0 5
NKCC1 (human) ELLSsQEksPGtkDV K943-ub
NKCC1 iso3 (human) ELLSSQEKSPGTKDV K943
NKCC1 (mouse) ELLSsQEksPGTkDV K936-ub
NKCC1 (rat) ELLSsQEKSPGTKDV K934
S944-p
LLSsQEksPGtkDVV
0 4
NKCC1 (human) LLSsQEksPGtkDVV S944-p
NKCC1 iso3 (human) LLSSQEKSPGTKDVV S944
NKCC1 (mouse) LLSsQEksPGTkDVV S937-p
NKCC1 (rat) LLSsQEKSPGTKDVV S935
T947-p
sQEksPGtkDVVVsV
0 1
NKCC1 (human) sQEksPGtkDVVVsV T947-p
NKCC1 iso3 (human) SQEKSPGTKDVVVSV T947
NKCC1 (mouse) sQEksPGTkDVVVNV T940
NKCC1 (rat) sQEKSPGTKDVVVNV T938
K948-ub
QEksPGtkDVVVsVE
0 7
NKCC1 (human) QEksPGtkDVVVsVE K948-ub
NKCC1 iso3 (human) QEKSPGTKDVVVSVE K948
NKCC1 (mouse) QEksPGTkDVVVNVD K941-ub
NKCC1 (rat) QEKSPGTKDVVVNVD K939
S953-p
GtkDVVVsVEyskkS
0 1
NKCC1 (human) GtkDVVVsVEyskkS S953-p
NKCC1 iso3 (human) GTKDVVVSVEYSKKS S953
NKCC1 (mouse) GTkDVVVNVDYSKKS N946
NKCC1 (rat) GTKDVVVNVDYSKKS N944
Y956-p
DVVVsVEyskkSDLD
0 22
NKCC1 (human) DVVVsVEyskkSDLD Y956-p
NKCC1 iso3 (human) DVVVSVEYSKKSDLD Y956
NKCC1 (mouse) DVVVNVDYSKKSDQD Y949
NKCC1 (rat) DVVVNVDYSKKSDQD Y947
S957-p
VVVsVEyskkSDLDT
0 1
NKCC1 (human) VVVsVEyskkSDLDT S957-p
NKCC1 iso3 (human) VVVSVEYSKKSDLDT S957
NKCC1 (mouse) VVVNVDYSKKSDQDT S950
NKCC1 (rat) VVVNVDYSKKSDQDA S948
K958-ub
VVsVEyskkSDLDTS
0 2
NKCC1 (human) VVsVEyskkSDLDTS K958-ub
NKCC1 iso3 (human) VVSVEYSKKSDLDTS K958
NKCC1 (mouse) VVNVDYSKKSDQDTC K951
NKCC1 (rat) VVNVDYSKKSDQDAF K949
K959-ub
VsVEyskkSDLDTSk
0 3
NKCC1 (human) VsVEyskkSDLDTSk K959-ub
NKCC1 iso3 (human) VSVEYSKKSDLDTSK K959
NKCC1 (mouse) VNVDYSKKSDQDTCK K952
NKCC1 (rat) VNVDYSKKSDQDAFK K950
K966-ub
kSDLDTSkPLSEkPI
Upstream
0 4
Treatment
  • vorinostat
NKCC1 (human) kSDLDTSkPLSEkPI K966-ub
NKCC1 iso3 (human) KSDLDTSKPLSEKPI K966
NKCC1 (mouse) KSDQDTCKSSGEKSI K959
NKCC1 (rat) KSDQDAFKASGEKPI K957
K971-ub
TSkPLSEkPITHkVE
0 4
NKCC1 (human) TSkPLSEkPITHkVE K971-ub
NKCC1 iso3 (human) TSKPLSEKPITHkES K971
NKCC1 (mouse) TCKSSGEKSITQKDE K964
NKCC1 (rat) AFKASGEKPITQKDE K962
K976-ub
SEkPITHkVEEEDGk
0 3
NKCC1 (human) SEkPITHkVEEEDGk K976-ub
NKCC1 iso3 (human) gap -
NKCC1 (mouse) GEKSITQKDEEEDGK K969
NKCC1 (rat) GEKPITQKDEEEDGK K967
K983-ub
kVEEEDGktATQPLL
0 4
NKCC1 (human) kVEEEDGktATQPLL K983-ub
NKCC1 iso3 (human) gap -
NKCC1 (mouse) KDEEEDGKTPTQPLL K976
NKCC1 (rat) KDEEEDGKTSTQPLL K974
T984-p
VEEEDGktATQPLLk
0 2
NKCC1 (human) VEEEDGktATQPLLk T984-p
NKCC1 iso3 (human) gap -
NKCC1 (mouse) DEEEDGKTPTQPLLk T977
NKCC1 (rat) DEEEDGKTSTQPLLK T975
K991-ub
tATQPLLkKEskGPI
0 3
NKCC1 (human) tATQPLLkKEskGPI K991-ub
NKCC1 iso3 (human) gap -
NKCC1 (mouse) TPTQPLLkKEskGPI K984-ub
NKCC1 (rat) TSTQPLLKKEsKGPV K982
-
under review
0 1
NKCC1 (human) under review -
NKCC1 iso3 (human) SEKPITHkESKGPIV K976-ub
NKCC1 (mouse) under review -
NKCC1 (rat) under review -
S994-p
QPLLkKEskGPIVPL
Upstream
0 16
Regulatory protein:
  • TBK1 (human)
Treatment
  • ischemia
  • metastatic potential
NKCC1 (human) QPLLkKEskGPIVPL S994-p
NKCC1 iso3 (human) KPITHkESKGPIVPL S978
NKCC1 (mouse) QPLLkKEskGPIVPL S987-p
NKCC1 (rat) QPLLKKEsKGPVAPL S985-p
K995-ub
PLLkKEskGPIVPLN
0 6
NKCC1 (human) PLLkKEskGPIVPLN K995-ub
NKCC1 iso3 (human) PITHkESKGPIVPLN K979
NKCC1 (mouse) PLLkKEskGPIVPLN K988-ub
NKCC1 (rat) PLLKKEsKGPVAPLN K986
K1007-ub
PLNVADQkLLEAsTQ
0 6
NKCC1 (human) PLNVADQkLLEAsTQ K1007-ub
NKCC1 iso3 (human) PLNVADQKLLEASTQ K991
NKCC1 (mouse) PLNVADQkLLEAsTQ K1000-ub
NKCC1 (rat) PLNVADQKLLEASTQ K998
S1012-p
DQkLLEAsTQFQkKQ
0 2
NKCC1 (human) DQkLLEAsTQFQkKQ S1012-p
NKCC1 iso3 (human) DQKLLEASTQFQKKQ S996
NKCC1 (mouse) DQkLLEAsTQFQkKQ S1005-p
NKCC1 (rat) DQKLLEASTQFQKKQ S1003
K1017-ub
EAsTQFQkKQGKNTI
0 5
NKCC1 (human) EAsTQFQkKQGKNTI K1017-ub
NKCC1 iso3 (human) EASTQFQKKQGKNTI K1001
NKCC1 (mouse) EAsTQFQkKQGKNTI K1010-ub
NKCC1 (rat) EASTQFQKKQGKNTI K1008
K1061-ub
IRVFIGGkINRIDHD
0 5
NKCC1 (human) IRVFIGGkINRIDHD K1061-ub
NKCC1 iso3 (human) IRVFIGGKINRIDHD K1045
NKCC1 (mouse) IRVFIGGkINRIDHD K1054-ub
NKCC1 (rat) IRVFIGGKINRIDHD K1052
T1074-p
HDRRAMAtLLSkFRI
0 1
NKCC1 (human) HDRRAMAtLLSkFRI T1074-p
NKCC1 iso3 (human) HDRRAMATLLSKFRI T1058
NKCC1 (mouse) HDRRAMATLLSkFRI T1067
NKCC1 (rat) HDRRAMATLLSkFRI T1065
K1078
AMAtLLSKFRIDFSD
0 1
NKCC1 (human) AMAtLLSKFRIDFSD K1078
NKCC1 iso3 (human) AMATLLSKFRIDFSD K1062
NKCC1 (mouse) AMATLLSKFRIDFSD K1071
NKCC1 (rat) AMATLLSkFRIDFSD K1069-ac
K1078-ub
AMAtLLSkFRIDFSD
0 2
NKCC1 (human) AMAtLLSkFRIDFSD K1078-ub
NKCC1 iso3 (human) AMATLLSKFRIDFSD K1062
NKCC1 (mouse) AMATLLSkFRIDFSD K1071-ub
NKCC1 (rat) AMATLLSKFRIDFSD K1069
K1095-ub
VLGDINTkPkkENII
0 5
NKCC1 (human) VLGDINTkPkkENII K1095-ub
NKCC1 iso3 (human) VLGDINTKPKKENII K1079
NKCC1 (mouse) VLGDINTkPKkENII K1088-ub
NKCC1 (rat) VLGDINTKPKKENIV K1086
K1097-ub
GDINTkPkkENIIAF
0 1
NKCC1 (human) GDINTkPkkENIIAF K1097-ub
NKCC1 iso3 (human) GDINTKPKKENIIAF K1081
NKCC1 (mouse) GDINTkPKkENIIAF K1090
NKCC1 (rat) GDINTKPKKENIVAF K1088
K1098-ub
DINTkPkkENIIAFE
Upstream
0 5
Treatment
  • vorinostat
NKCC1 (human) DINTkPkkENIIAFE K1098-ub
NKCC1 iso3 (human) DINTKPKKENIIAFE K1082
NKCC1 (mouse) DINTkPKkENIIAFD K1091-ub
NKCC1 (rat) DINTKPKKENIVAFD K1089
K1098-sm
DINTkPkkENIIAFE
0 1
NKCC1 (human) DINTkPkkENIIAFE K1098-sm
NKCC1 iso3 (human) DINTKPKKENIIAFE K1082
NKCC1 (mouse) DINTkPKKENIIAFD K1091
NKCC1 (rat) DINTKPKKENIVAFD K1089
K1118-ub
YRLHEDDkEQDIADk
0 2
NKCC1 (human) YRLHEDDkEQDIADk K1118-ub
NKCC1 iso3 (human) YRLHEDDKEQDIADK K1102
NKCC1 (mouse) YRLHEDDKEQDIADK K1111
NKCC1 (rat) YRLHEDDKEQDIADK K1109
K1125-ub
kEQDIADkMkEDEPW
Upstream
0 3
Treatment
  • vorinostat
NKCC1 (human) kEQDIADkMkEDEPW K1125-ub
NKCC1 iso3 (human) KEQDIADKMKEDEPW K1109
NKCC1 (mouse) KEQDIADKMKEDEPW K1118
NKCC1 (rat) KEQDIADKMKEDEPW K1116
K1127-ub
QDIADkMkEDEPWRI
0 2
NKCC1 (human) QDIADkMkEDEPWRI K1127-ub
NKCC1 iso3 (human) QDIADKMKEDEPWRI K1111
NKCC1 (mouse) QDIADKMKEDEPWRI K1120
NKCC1 (rat) QDIADKMKEDEPWRI K1118
K1143
DNELELYKTKTYRQI
0 1
NKCC1 (human) DNELELYKTKTYRQI K1143
NKCC1 iso3 (human) DNELELYKTKTYRQI K1127
NKCC1 (mouse) DNELELYKTKTYRQI K1136
NKCC1 (rat) DNELELYkTKTYRQI K1134-ac
K1143-ub
DNELELYkTKTYRQI
0 2
NKCC1 (human) DNELELYkTKTYRQI K1143-ub
NKCC1 iso3 (human) DNELELYKTKTYRQI K1127
NKCC1 (mouse) DNELELYKTKTYRQI K1136
NKCC1 (rat) DNELELYKTKTYRQI K1134
Y1211-p
HQSVLTFys______
0 5
NKCC1 (human) HQSVLTFys______ Y1211-p
NKCC1 iso3 (human) HQSVLTFYS______ Y1195
NKCC1 (mouse) HQSVLTFYS______ Y1204
NKCC1 (rat) HQSVLTFYS______ Y1202
S1212-p
QSVLTFys_______
0 2
NKCC1 (human) QSVLTFys_______ S1212-p
NKCC1 iso3 (human) QSVLTFYS_______ S1196
NKCC1 (mouse) QSVLTFYS_______ S1205
NKCC1 (rat) QSVLTFYS_______ S1203